Lamisil 1% Cream
LAMISIL® 1% CREAM / TERBINAFINE HYDROCHLORIDE 1% CREAM
This product is available using one of the above names but will be referred to as Lamisil Cream throughout this leaflet.
■ Keep this leaflet. You may need to read it again.
■ If you have any further questions, ask your doctor or pharmacist.
■ This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
■ If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
1. What Lamisil Cream is and what it is used for
2. Before you use Lamisil Cream
3. How to use Lamisil Cream
4. Possible side effects
5. How to store Lamisil Cream
6. Further information
Lamisil Cream is used to treat patients with fungal and certain yeast infections of the skin. It attacks and kills the fungus or yeast which is causing your infection.
■ are allergic (hypersensitive) to any of the ingredients in the product (see Section 6)
The cream is NOT recommended for use on children.
The cream is for external use only. Do not use on the face. Avoid contact with eyes. In case of accidental contact with eyes, rinse thoroughly with running water.
Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including those obtained without a prescription.
Do not use the cream if you are pregnant or breast-feeding, unless advised to by your doctor. Ask your doctor or pharmacist for advice before taking any medicine.
Lamisil Cream is not expected to affect your ability to drive or operate machinery.
■ cetyl alcohol and stearyl alcohol: May cause local skin reactions (e.g. contact dermatitis).
For other ingredients see Section 6.
Your doctor will decide the right amount of Lamisil Cream for you to use and will tell you for how long to use your medication.
Apply the cream once or twice a day, for one to two weeks, but this will depend upon the type and area of infection. Infections usually appear to improve within a few days of starting to use Lamisil Cream, but may reappear if the cream is not applied regularly or is stopped too early.
■ Cleanse and dry the affected areas thoroughly and wash your hands. Treatment can be helped by keeping the affected areas clean by regular washing and careful drying with your own clean towels and clothes, and not rubbing or scratching the skin.
■ Unscrew the cap then gently squeeze out a small amount of the cream onto your finger.
■ Apply just enough cream to form a thin layer on the affected skin and surrounding areas.
■ Rub in gently. When used between the toes, buttocks or on the groin, the treated area may be covered with a light, fresh gauze strip, especially at night.
■ Replace the cap on the tube and wash your hands.
Even though you will not be using Lamisil Cream during the second week for athlete's foot, full skin healing after the infection has cleared will continue for up to 4 weeks. If you have not noticed any signs of improvement within 2 weeks of first starting treatment, please seek advice from your doctor or pharmacist.
Use in children is NOT recommended, since there are no data to support use in this population.
Contact your doctor or nearest hospital emergency department if you, or someone else, has swallowed some cream. Take any remaining medicine and this leaflet with you if possible. Symptoms of accidental ingestion include headache, nausea (feeling sick), dizziness and stomach pain.
If you miss an application, apply the cream as soon as possible then continue your treatment as before. If you only remember at the time of your next application, just apply the cream and carry on as normal. It is important to try to use the cream at the correct times as forgotten applications could risk the infection returning.
Infections may come back if you do not use the cream regularly, or if you stop the treatment too early.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Lamisil Cream can cause side effects, although not everybody gets them.
STOP using the cream and seek medical help immediately if you have any of the following very rare allergic reactions:
■ difficulty breathing or swallowing, swelling of the mouth, face, lips, tongue or throat (severe allergic reaction).
■ severe itching of the skin, with a red rash or raised lumps, hives or blisters.
Common: (may affect up to 1 in 10 people): skin peeling, itching.
Uncommon: (may affect up to 1 in 100 people): skin lesions, scab, skin colour changes, redness, burning, pain and irritation at the site of application.
These common and uncommon side effects are usually harmless and you can carry on using the cream.
Rare: (may affect up to 1 in 1000 people): eye irritation, dry skin, contact dermatitis, eczema, worsening of symptoms.
If any of these side effects get serious, or if you notice any side effect not listed in this leaflet, please tell your doctor.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children. Your medicine could harm them.
Replace the cap on the tube after use.
Expiry date: Do not use this product after the expiry date printed on the carton.
If your doctor decides to stop your treatment, return any leftover medication to the pharmacist for safe disposal.
If your cream appears to be discoloured or show any other signs of deterioration, please return to your pharmacist who will advise you.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.
Lamisil Cream contains terbinafine hydrochloride 1% w/w.
The cream also contains the following inactive ingredients: sodium hydroxide, benzyl alcohol, sorbitan monostearate, cetyl palmitate, cetyl alcohol, stearyl alcohol, polysorbate 60, isopropyl myristate and purified water.
Lamisil Cream is a white, smooth cream in an aluminium tube with a white screw cap.
Lamisil Cream is available in tubes of 15g or 30g.
Novartis Pharma Productions GmbH, Wehr, Germany.
Procured from within the EU and repackaged by: Doncaster Pharmaceuticals Group Ltd., Kirk Sandall, Doncaster, DN3 1QR.
Product Licence holder:
Doncaster Pharmaceuticals Group Ltd., Kirk Sandall, Doncaster, DN3 1QR.
PL No: 04423/0526
Leaflet revision & issue date: 09.12.15 LAMISIL® is a registered trademark of Novartis AG.
Page 2 of 2